GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » GF Value

ALR Technologies SG (ALR Technologies SG) GF Value : $0.00 (As of May. 04, 2024)


View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-04), ALR Technologies SG's share price is $0.021. ALR Technologies SG's GF Value is $0.00. Therefore, ALR Technologies SG's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes ALR Technologies SG is Not Valued.


ALR Technologies SG  (OTCPK:ALRTF) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

ALR Technologies SG's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.021/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ALR Technologies SG GF Value Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ALR Technologies SG (ALR Technologies SG) Business Description

Traded in Other Exchanges
N/A
Address
7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225
ALR Technologies SG Ltd formerly ALR Technologies Inc is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, Singapore, and Others.
Executives
Sidney Chan director, officer: CEO 7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng director 255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford director 1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith director, officer: Chief Commercial Officer 46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak director 521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas director 2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein director, officer: President 13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy officer: Vice-President - Technologies 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt director, 10 percent owner, officer: President 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106